Opna Bio, a clinical-stage biopharmaceutical company focused on the discovery and development of novel oncology therapeutics, announced today that the FDA has granted orphan drug designation (ODD) to ...

We studied bone marrow (BM) plasma from 22 MM patients ... CCL3 and osteopontin (OPN) expression was analyzed by ELISA assays purchased from R&D Systems and OCN levels were assessed using the ...